{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:25:07Z","timestamp":1767896707042,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00347-018-0746-5","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T03:23:08Z","timestamp":1529032988000},"page":"553-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-Life-Daten-Analyse der Therapiequalit\u00e4t bei Patienten mit exsudativer altersabh\u00e4ngiger Makuladegeneration (AMD) und ven\u00f6sen Gef\u00e4\u00dfverschl\u00fcssen an einer deutschen Universit\u00e4tsaugenklinik","Analysis of real-life data on treatment quality in patients with exudative age-related macular degeneration (AMD) and vein occlusion at a German university eye hospital"],"prefix":"10.1007","volume":"116","author":[{"given":"M.","family":"Treder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rudloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Eter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"746_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00347-014-3124-y","volume":"112","author":"M Alnawaiseh","year":"2015","unstructured":"Alnawaiseh M, Alten F, Huelsken G et\u00a0al (2015) Implementierung einer elektronischen Patientenakte an einer deutschen Augenklinik der Maximalversorgung. Ophthalmologe 112:337\u2013345","journal-title":"Ophthalmologe"},{"key":"746_CR2","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","volume":"118","author":"DM Brown","year":"2011","unstructured":"Brown DM, Campochiaro PA, Bhisitkul RB et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a\u00a0phase III study. Ophthalmology 118:1594\u20131602","journal-title":"Ophthalmology"},{"key":"746_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"DM Brown","year":"2009","unstructured":"Brown DM, Michels M, Kaiser PK et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57\u201365","journal-title":"Ophthalmology"},{"key":"746_CR4","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ophtha.2012.10.014","volume":"120","author":"BG Busbee","year":"2013","unstructured":"Busbee BG, Ho AC, Brown DM et al (2013) Twelve-month efficacy and safety of 0.5\u202fmg or 2.0\u202fmg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 120:1046\u20131056","journal-title":"Ophthalmology"},{"key":"746_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","volume":"122","author":"P Campochiaro","year":"2015","unstructured":"Campochiaro P, Clark W, Boyer D et al (2015) Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology 122:538\u2013544","journal-title":"Ophthalmology"},{"key":"746_CR6","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","volume":"118","author":"PA Campochiaro","year":"2011","unstructured":"Campochiaro PA, Brown DM, Awh CC et al (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a\u00a0phase III study. Ophthalmology 118:2041\u20132049","journal-title":"Ophthalmology"},{"key":"746_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","volume":"382","author":"U Chakravarthy","year":"2013","unstructured":"Chakravarthy U, Harding SP, Rogers CA et al (2013) Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2\u2011year findings of the IVAN randomised controlled trial. Lancet 382:1258\u20131267","journal-title":"Lancet"},{"key":"746_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","volume":"119","author":"U Chakravarthy","year":"2012","unstructured":"Chakravarthy U, Harding SP, Rogers CA et al (2012) Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 119:1399\u20131411","journal-title":"Ophthalmology"},{"key":"746_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/IAE.0000000000001579","volume":"38","author":"I Chatziralli","year":"2017","unstructured":"Chatziralli I, Theodossiadis G, Chatzirallis A et al (2017) Ranibizumab for retinal vein occlusion: predictive factors and long-term outcomes in real-life data. Retina 38:559\u2013568","journal-title":"Retina"},{"key":"746_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.survophthal.2016.01.003","volume":"61","author":"A Clark","year":"2016","unstructured":"Clark A, Ng JQ, Morlet N et\u00a0al (2016) Big data and ophthalmic research. Surv Ophthalmol 61:443\u2013465","journal-title":"Surv Ophthalmol"},{"key":"746_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00347-015-0115-6","volume":"112","author":"N Feltgen","year":"2015","unstructured":"Feltgen N, Pielen A (2015) Retinaler Venenverschluss \u2013 Therapie des retinalen Gef\u00e4\u00dfverschlusses. Ophthalmologe 112:695\u2013706","journal-title":"Ophthalmologe"},{"key":"746_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1755-3768.2012.02493.x","volume":"91","author":"RP Finger","year":"2013","unstructured":"Finger RP, Wiedemann P, Blumhagen F et al (2013) Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study \u2013 a\u00a0noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol (Copenh) 91:540\u2013546","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"746_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00103-013-1896-x","volume":"57","author":"Graf D Stillfried Von","year":"2014","unstructured":"Graf Von Stillfried D, Czihal T (2014) Welchen Beitrag liefern funktional definierte Populationen zur Erkl\u00e4rung regionaler Unterschiede in der medizinischen Versorgung? Bundesgesundheitsblatt 57:197\u2013206","journal-title":"Bundesgesundheitsblatt"},{"key":"746_CR14","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ophtha.2014.01.027","volume":"121","author":"J Heier","year":"2014","unstructured":"Heier J, Clark W, Boyer D et al (2014) Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology 121:1414\u20131420","journal-title":"Ophthalmology"},{"key":"746_CR15","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:2537\u20132548","journal-title":"Ophthalmology"},{"key":"746_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","volume":"99","author":"F Holz","year":"2015","unstructured":"Holz F, Tadayoni R, Beatty S et al (2015) Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol 99:220\u2013226","journal-title":"Br J Ophthalmol"},{"key":"746_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/bjophthalmol-2013-303232","volume":"97","author":"FG Holz","year":"2013","unstructured":"Holz FG, Bandello F, Gillies M et al (2013) Safety of ranibizumab in routine clinical practice: 1\u2011year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme. Br J Ophthalmol 97:1161\u20131167","journal-title":"Br J Ophthalmol"},{"key":"746_CR18","unstructured":"Schulz B (2011) Zweiklassenmedizin: \u00c4rzte diskriminieren Kassenpatienten systematisch. \n                    http:\/\/www.spiegel.de\/wirtschaft\/soziales\/zweiklassenmedizin-aerzte-diskriminieren-kassenpatienten-systematisch-a-774882.html\n                    \n                  . Zugegriffen: 01. Mai 2018"},{"key":"746_CR19","first-page":"141","volume-title":"Gesundheitliche Ungleichheit","author":"C Jan\u00dfen","year":"2009","unstructured":"Jan\u00dfen C, Grosse Frie K, Ommen O (2009) Der Einfluss von sozialer Ungleichheit auf die medizinische und gesundheitsbezogene Versorgung in Deutschland. In: Richter M, Hurrelmann K (Hrsg) Gesundheitliche Ungleichheit. VS, Wiesbaden, S\u00a0141\u2013155"},{"key":"746_CR20","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ophtha.2016.07.037","volume":"123","author":"R Johnston","year":"2016","unstructured":"Johnston R, Lee A, Buckle M et al (2016) UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) users group report IV: incidence of blindness and sight impairment in ranibizumab-treated patients. Ophthalmology 123:2386\u20132392","journal-title":"Ophthalmology"},{"key":"746_CR21","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-303233","volume":"97","author":"TD Keenan","year":"2013","unstructured":"Keenan TD, Kelly SP, Sallam A et al (2013) Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a\u00a0well-defined region of the UK. Br J Ophthalmol 97:1168\u20131172","journal-title":"Br. J. Ophthalmol."},{"key":"746_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ophtha.2013.08.012","volume":"121","author":"J Korobelnik","year":"2014","unstructured":"Korobelnik J, Holz F, Roider J et al (2014) Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology 121:202\u2013208","journal-title":"Ophthalmology"},{"key":"746_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00347-016-0272-2","volume":"113","author":"K Kort\u00fcm","year":"2016","unstructured":"Kort\u00fcm K, M\u00fcller M, Hirneiss C et al (2016) \u201eSmart eye data\u201c. Entwicklung eines Fundaments f\u00fcr medizinische Forschung mittels Smart-Data-Applikationen. Ophthalmologe 113:469\u2013477","journal-title":"Ophthalmologe"},{"key":"746_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00347-015-0072-0","volume":"112","author":"K Kort\u00fcm","year":"2015","unstructured":"Kort\u00fcm K, M\u00fcller M, Babenko A et\u00a0al (2015) Entwicklung eines augen\u00e4rztlichen klinischen Informationssystems f\u00fcr bettenf\u00fchrende Augenkliniken. Ophthalmologe 112:995\u20131001","journal-title":"Ophthalmologe"},{"key":"746_CR25","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s00347-004-1048-7","volume":"101","author":"J Kuchenbecker","year":"2004","unstructured":"Kuchenbecker J, Behrens-Baumann W (2004) Einsatz einer elektronischen Patientenakte (EPA) an der Universit\u00e4tsaugenklinik Magdeburg. Ophthalmologe 101:1214\u20131219","journal-title":"Ophthalmologe"},{"key":"746_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/bjophthalmol-2014-306229","volume":"99","author":"AY Lee","year":"2015","unstructured":"Lee AY, Lee CS, Butt T et\u00a0al (2015) UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6\/12. Br J Ophthalmol 99:1045\u20131050","journal-title":"Br J Ophthalmol"},{"key":"746_CR27","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","volume":"119","author":"DF Martin","year":"2012","unstructured":"Martin DF, Maguire MG, Fine SL et al (2012) Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119:1388\u20131398","journal-title":"Ophthalmology"},{"key":"746_CR28","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMicm1005605","volume":"364","author":"DF Martin","year":"2011","unstructured":"Martin DF, Maguire MG, Ying GS et al (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N\u00a0Engl J Med 364:1897\u20131908","journal-title":"N Engl J Med"},{"key":"746_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-017-0588-6","author":"C Spira-Eppig","year":"2017","unstructured":"Spira-Eppig C, Eppig T, Bischof M et al (2017) Per aspera ad astra: implementation of electronic patient records in a\u00a0university eye hospital: experience with FIDUS in the Clinic for Ophthalmology at the Saarland University Medical Center UKS. Ophthalmologe. \n                    https:\/\/doi.org\/10.1007\/s00347-017-0588-6","journal-title":"Ophthalmologe"},{"key":"746_CR30","volume-title":"Die Anti-VEGF-Therapie bei der neovaskul\u00e4ren altersabh\u00e4ngigen Makuladegeneration: Therapeutische Strategien","author":"Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands","year":"2014","unstructured":"Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands (2014) Die Anti-VEGF-Therapie bei der neovaskul\u00e4ren altersabh\u00e4ngigen Makuladegeneration: Therapeutische Strategien"},{"key":"746_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2196\/medinform.2913","volume":"2","author":"W Wang","year":"2014","unstructured":"Wang W, Krishnan E (2014) Big data and clinicians: a\u00a0review on the state of the science. JMIR Med Inform 2:e1","journal-title":"JMIR Med. Inform."},{"key":"746_CR32","first-page":"353","volume":"101","author":"T Wecker","year":"2017","unstructured":"Wecker T, Ehlken C, B\u00fchler A et al (2017) Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV. Br J Ophthalmol 101:353\u2013359","journal-title":"Br J Ophthalmol"},{"key":"746_CR33","first-page":"5","volume-title":"Wei\u00dfbuch zur Situation der ophthalmologischen Versorgung in Deutschland","author":"C Wolfram","year":"2012","unstructured":"Wolfram C, Pfeiffer N (2012) Der Bedarf ophthalmologischer Versorgung. In: Deutsche Ophthalmologische Gesellschaft (Hrsg) Wei\u00dfbuch zur Situation der ophthalmologischen Versorgung in Deutschland. DOG, M\u00fcnchen, S\u00a05\u201310"},{"key":"746_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00347-014-3217-7","volume":"112","author":"F Ziemssen","year":"2015","unstructured":"Ziemssen F, Eter N, Fauser S et al (2015) Retrospektive Untersuchung der Anti-VEGF-Behandlungsrealit\u00e4t und Wirksamkeit bei Patienten mit neovaskul\u00e4rer altersabh\u00e4ngiger Makuladegeneration (nAMD) in Deutschland. Ophthalmologe 112:246\u2013254","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-018-0746-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T19:09:51Z","timestamp":1560539391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-018-0746-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s00347-018-0746-5","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"15 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Treder, A.\u00a0Gaber, B.\u00a0Rudloff und N.\u00a0Eter geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen wurden im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}